Last reviewed · How we verify
Intrathecal Mafosfamide
At a glance
| Generic name | Intrathecal Mafosfamide |
|---|---|
| Sponsor | Baylor College of Medicine |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- Study of Systemic and Spinal Chemotherapy Followed by Radiation for Infants With Brain Tumors (NA)
- Intrathecal Mafosfamide (PHASE1)
- Mafosfamide in Treating Patients With Progressive or Refractory Meningeal Tumors (PHASE1)
- Phase I Study of Intrathecal Mafosfamide (PHASE1)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |